[ad_1]
Onyx Equities has unveiled plans for The Northeast Science and Technology Center, or NEST, as it prepares a broader campaign to attract new life sciences and biotechnology firms to the 2 million-square-foot former Merck & Co. campus in Kenilworth. — Renderings courtesy: Onyx
By Joshua Burd
Onyx Equities has revealed new details of its plan for the 2 million-square-foot former Merck & Co. campus in Kenilworth, as it prepares a broad campaign to attract life sciences and biotechnology firms seeking both turnkey space and new ground-up facilities.
The firm, which acquired the property earlier this year in partnership with Machine Investment Group, has branded the site as The Northeast Science and Technology Center, or NEST. It’s now slated to share additional plans for the 108-acre campus at next month’s BIO International Convention in Boston, pitching a purpose-built research and development hub 14 miles from New York City, with access to the region’s deep pool of life sciences talent.
A marketing team for NEST will be on hand with a booth at the conference, which runs from June 5 to 8 at the Boston Convention & Exhibition Center, touting highlights such as:
- 4 million square feet of laboratory buildings
- 30 acres of redevelopment opportunities specifically zoned for research, laboratories and manufacturing facilities
- 500,000 square feet of high-end professional office space
- A turnkey vivarium
- Robust and redundant utility infrastructure, including a 25-megawatt co-generation power plant
- State-of-the-art amenities to create a vibrant campus culture, including a heliport, fitness center, conference centers and green space
“The biotechnology industry has a high demand for both turnkey and customizable solutions,” said John Saraceno, co-founder and managing principal for Onyx, who also serves as co-founder and managing partner of the NEST Center. “Prior to NEST, many health tech companies, especially those in research and development, were forced to wait years for adequate laboratory and workspace. NEST allows those on the cutting edge of medicine to focus on finding cures — rather than an office location.”
The rollout comes just under a month after Onyx signed a lease with Kenvue Inc., Johnson & Johnson’s billion-dollar consumer health spinoff, at a separate property in New Jersey. The latter, which recently went public, will lease 290,000 square feet of office and lab space as part of a plan to open its headquarters the developer’s Summit East property.
Saraceno added that Onyx chose to announce NEST at this year’s BIO Convention in Boston because the event has a reputation for bringing together leaders, innovators and investors in the life science, biotech, and medical device industries. The firm now hopes to position the property as a hub of research and innovation in the Northeast.
Demand for lab, R&D space in New Jersey still surging as developers hunt for new supply
[ad_2]
Source link
